Carregant...

Biomarkers and Surrogate Endpoints In Clinical Trials

One of the most important considerations in designing clinical trials is the choice of outcome measures. These outcome measures could be clinically meaningful endpoints that are direct measures of how patients feel, function and survive. Alternatively, indirect measures, such as biomarkers that incl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fleming, Thomas R., Powers, John H
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3551627/
https://ncbi.nlm.nih.gov/pubmed/22711298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.5403
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!